Geographic Disparity: Analyzing Regional Variances in CDx Adoption and Investment
  The adoption and penetration of Companion Diagnostics (CDx) in oncology are characterized by significant regional disparities, directly reflecting differences in healthcare infrastructure, regulatory environments, and reimbursement policies across the globe. North America, particularly the United States, represents the largest and most mature Companion Diagnostics for Oncology Market...
0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр